CRM
COV

Cramer Rosenthal McGlynn’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Cramer Rosenthal McGlynn’s Portfolio COV Stock Details COV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-454,820
Closed -$33.5M – 300
2014
Q1 		$33.5M Sell
454,820
-248,540
-35% -$17.3M 0.26% 120
2013
Q4 		$47.9M Sell
703,360
-10,615
-1% -$691K 0.34% 106
2013
Q3 		$43.5M Sell
713,975
-108,269
-13% -$6.61M 0.33% 108
2013
Q2 		$45.8M Buy
+822,244
New +$47.5M 0.35% 105

Other funds holding COV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Cramer Rosenthal McGlynn's COV Position: Q2 2014 in Review

Cramer Rosenthal McGlynn sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q2 2014, closing a stake of 454,820 shares — an estimated $33.5M sold.

Cramer Rosenthal McGlynn first reported a position in COV in Q2 2013 and held it in 4 quarters. The position peaked at $47.9M in Q4 2013. 804 funds tracked by Wall St. Rank hold COV as of Q2 2014.

  • Cramer Rosenthal McGlynn reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q2 2014 after selling out during the quarter.
  • Cramer Rosenthal McGlynn sold 454,820 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q2 2014, an estimated $33.5M.
  • Cramer Rosenthal McGlynn first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 4 quarters.
  • Cramer Rosenthal McGlynn's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $47.9M in Q4 2013.
  • 804 funds tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q2 2014.

Based on Cramer Rosenthal McGlynn's 13F filing for Q2 2014, filed 14 Aug 2014.